Skip to main content

Table 2 Results of other potential covariates in ALS patients between different HbA1c status (N = 450)

From: Blood hemoglobin A1c levels and amyotrophic lateral sclerosis survival

HbA1c, %

<5.7

5.7–6.4

≥6.5

P-trend

Number

263

152

35

 

BMI, kg/m2

22.3(3.3)

22.0(3.0)

22.7(3.1)

0.57

BMI status

 Normal, %

84.8

86.2

82.9

0.79

 Overweight, %

14.4

13.8

17.1

 

 Obesity, %

0.8

0.0

0.0

 

Smoking, %

32.3

29.6

31.4

0.85

Alcohol drinking, %

32.7

26.3

25.7

0.33

Hypertension, %

11.8

19.7

17.1

0.08

Anemia, %

7.2

5.3

8.6

0.67

Erythrocytes, 10^12/L

4.5(0.5)

4.6(0.5)

4.7(0.5)

0.003

Platelets, 10^9/L

164.1(54.9)

171.8(55.9)

193.6(58.0)

0.01

Total leukocytes, 10^9/L

5.6(1.4)

5.9(2.0)

7.0(2.9)

<0.001

Neutrophils, 10^9/L

3.4(1.2)

3.7(1.8)

4.5(2.2)

0.001

Lymphocytes, 10^9/L

1.6(0.5)

1.7(0.5)

2.0(0.8)

0.001

Monocytes, 10^9/L

0.3(0.1)

0.4(0.1)

0.4(0.2)

<0.001

Triglyceride, mmol/L

1.4(0.9)

1.4(0.7)

2.2(1.8)

<0.001

Total Cholesterol, mmol/L

4.5(0.8)

4.8(0.9)

5.0(1.2)

<0.001

Use of hypoglycemic agents, %

0.0

0.0

60.0

<0.001

  1. Abbreviations: ALS amyotrophic lateral sclerosis, HbA1c Hemoglobin A1c, BMI body mass index